Jordan Zuckerman, MD
Procedural Dermatology · Bayside, NYNPI 1043205016
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,651 of the $8,876 with a category attached, or 86.2%. It is spread thinly across 36 manufacturers, the largest accounting for just 10.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,185 and has fallen 52.7% since, to $1,033 in 2025.
Across 297 payments — averaging $29.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$945
- AbbVie$903
- Novartis$779
- Bristol Myers Squibb$649
- Lilly USA, LLC$420
- Revance Therapeutics, Inc.$394
- plus $5K from 30 others
Across 5 payments — averaging $25,787 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$129K
What the payments were for
- Consulting fees$7158%
- Food & beverage$7,65186%
- Education$5106%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 25 | $945 |
| AbbVie(2 entities) | 36 | $903 |
| Novartis | 35 | $779 |
| Bristol Myers Squibb | 5 | $649 |
| Lilly USA, LLC | 10 | $420 |
| Revance Therapeutics, Inc. | 5 | $394 |
| Arcutis Biotherapeutics, Inc. | 7 | $370 |
| E.r. Squibb & Sons, L.L.C. | 14 | $360 |
| Pfizer | 12 | $358 |
| Incyte Corporation | 16 | $346 |
| Genentech USA, Inc. | 15 | $338 |
| Sun Pharmaceutical Industries Inc. | 11 | $328 |
| Galderma Laboratories, L.p. | 17 | $272 |
| LEO Pharma Inc. | 19 | $269 |
| VYNE Pharmaceuticals Inc. | 8 | $249 |
| Merz North America, Inc. | 3 | $245 |
| Mayne Pharma Commercial LLC | 12 | $234 |
| Botanix SB Inc | 10 | $194 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 4 | $145 |
| Janssen Scientific Affairs, LLC | 1 | $125 |
| Journey Medical Corporation | 1 | $125 |
| UCB, Inc. | 1 | $119 |
| Encore Dermatology Inc. | 6 | $112 |
| Comsort, Inc | 1 | $100 |
| Amgen | 3 | $87 |
| EPI Health, LLC | 4 | $69 |
| Almirall LLC | 3 | $68 |
| Dermavant Sciences, Inc. | 3 | $52 |
| Sanofi | 2 | $47 |
| Merck | 2 | $29 |
| Organon | 1 | $27 |
| Boehringer Ingelheim | 1 | $27 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| Organogenesis Inc. | 1 | $22 |
| Sientra, Inc. | 1 | $22 |
| Verrica Pharmaceuticals Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,876 in reported general payments places this provider in the 65th percentile of 69 procedural dermatology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 131 | $6,902 |
| Tavaborole | 12 | $5,526 |
| Tacrolimus | 29 | $5,442 |
| Fluocinolone Acetonide | 108 | $4,460 |
| Betamethasone Dipropionate | 116 | $3,531 |
| Ketoconazole | 117 | $2,574 |
| Fluorouracil | 37 | $2,170 |
| Halobetasol Propionate | 39 | $1,852 |
| Metronidazole | 27 | $1,723 |
| Mometasone Furoate | 73 | $1,053 |
| Fluocinonide | 17 | $827 |
| Gentamicin Sulfate | 20 | $776 |
| Triamcinolone Acetonide | 37 | $594 |
| Cephalexin | 71 | $474 |
| Doxycycline Hyclate | 32 | $437 |
Paid to pharmacies, not to this prescriber.
Other procedural dermatology in Bayside
- Joseph SchwartzTroy$470K
- Michelle HenryNew York$460K
- Jerry ShapiroNew York$414K
- Jared JagdeoBrooklyn$362K
- Dendy EngelmanNew York$292K
- Evan RiederNew York$210K
- Daniel Belkin-HollandNew York$208K
- Suzanne Sirota-RozenbergWoodmere$122K
- Robert BacigalupiGarden City$109K
- Anthony ChiaravallotiEast Syracuse$90K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.